Gender
Visit number vs Average duration of central apneas with no oxygen desaturation threshold used during estimated sleep from type III home sleep apnea test
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 163 | 17.0 | ± 3.6 | 16.8 | 10.2 | 28.6 | 155 | 318 |
Follow-up | 123 | 17.0 | ± 4.3 | 15.9 | 10.2 | 29.6 | 178 | 301 |
Treatment Arm vs Average duration of central apneas with no oxygen desaturation threshold used during estimated sleep from type III home sleep apnea test
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 163 | 17.0 | ± 3.6 | 16.8 | 10.2 | 28.6 | 155 | 318 |
Healthy Lifestyles and Sleep Education - control arm (HLSE) | 53 | 16.5 | ± 3.5 | 15.9 | 11.6 | 28.6 | 53 | 106 |
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) | 60 | 17.1 | ± 3.2 | 17.3 | 11.6 | 26.2 | 46 | 106 |
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) | 50 | 17.5 | ± 4.0 | 17.2 | 10.2 | 26.9 | 56 | 106 |
Treatment Arm vs Average duration of central apneas with no oxygen desaturation threshold used during estimated sleep from type III home sleep apnea test
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 123 | 17.0 | ± 4.3 | 15.9 | 10.2 | 29.6 | 178 | 301 |
Healthy Lifestyles and Sleep Education - control arm (HLSE) | 48 | 16.9 | ± 4.6 | 15.5 | 10.9 | 29.6 | 52 | 100 |
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) | 38 | 17.4 | ± 3.9 | 16.5 | 10.7 | 27.7 | 63 | 101 |
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) | 37 | 16.9 | ± 4.6 | 16.6 | 10.2 | 27.0 | 63 | 100 |
Age category vs Average duration of central apneas with no oxygen desaturation threshold used during estimated sleep from type III home sleep apnea test
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 163 | 17.0 | ± 3.6 | 16.8 | 10.2 | 28.6 | 155 | 318 |
45-54 years | 23 | 15.9 | ± 2.9 | 15.9 | 11.2 | 21.2 | 30 | 53 |
55-64 years | 61 | 16.5 | ± 3.7 | 15.7 | 10.2 | 26.9 | 78 | 139 |
65 years or older | 79 | 17.8 | ± 3.5 | 17.3 | 11.8 | 28.6 | 47 | 126 |
Age category vs Average duration of central apneas with no oxygen desaturation threshold used during estimated sleep from type III home sleep apnea test
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 123 | 17.0 | ± 4.3 | 15.9 | 10.2 | 29.6 | 177 | 300 |
45-54 years | 25 | 14.9 | ± 3.7 | 13.9 | 10.2 | 23.9 | 24 | 49 |
55-64 years | 46 | 16.3 | ± 3.9 | 15.4 | 10.9 | 27.7 | 81 | 127 |
65 years or older | 52 | 18.7 | ± 4.5 | 18.2 | 10.7 | 29.6 | 72 | 124 |
Gender of the participant vs Average duration of central apneas with no oxygen desaturation threshold used during estimated sleep from type III home sleep apnea test
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 163 | 17.0 | ± 3.6 | 16.8 | 10.2 | 28.6 | 155 | 318 |
Female | 42 | 16.2 | ± 3.7 | 14.8 | 10.2 | 25.0 | 42 | 84 |
Male | 121 | 17.3 | ± 3.5 | 17.0 | 11.4 | 28.6 | 113 | 234 |
Gender of the participant vs Average duration of central apneas with no oxygen desaturation threshold used during estimated sleep from type III home sleep apnea test
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 123 | 17.0 | ± 4.3 | 15.9 | 10.2 | 29.6 | 178 | 301 |
Female | 23 | 15.5 | ± 3.5 | 15.0 | 11.1 | 24.0 | 56 | 79 |
Male | 100 | 17.4 | ± 4.4 | 16.7 | 10.2 | 29.6 | 122 | 222 |
Race of the participant vs Average duration of central apneas with no oxygen desaturation threshold used during estimated sleep from type III home sleep apnea test
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 162 | 17.0 | ± 3.6 | 16.7 | 10.2 | 28.6 | 155 | 317 |
White | 133 | 17.3 | ± 3.6 | 16.9 | 10.2 | 28.6 | 123 | 256 |
American Indian or Alaskan Native | 1 | 17.5 | - | 17.5 | 17.5 | 17.5 | 1 | 2 |
Black or African American | 20 | 16.8 | ± 3.2 | 16.6 | 12.5 | 25.0 | 23 | 43 |
Asian | 2 | 15.1 | ± 3.8 | 15.1 | 12.4 | 17.8 | 4 | 6 |
Native Hawaiian or other Pacific islander | 1 | 13.5 | - | 13.5 | 13.5 | 13.5 | - | 1 |
Other | 2 | 16.2 | ± 3.5 | 16.2 | 13.7 | 18.6 | 2 | 4 |
Multiple | 3 | 11.6 | ± 0.4 | 11.6 | 11.2 | 12.0 | 2 | 5 |
Race of the participant vs Average duration of central apneas with no oxygen desaturation threshold used during estimated sleep from type III home sleep apnea test
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 122 | 17.0 | ± 4.4 | 16.0 | 10.2 | 29.6 | 177 | 299 |
White | 102 | 17.2 | ± 4.3 | 16.2 | 10.2 | 27.7 | 139 | 241 |
American Indian or Alaskan Native | 1 | 13.1 | - | 13.1 | 13.1 | 13.1 | 1 | 2 |
Black or African American | 12 | 17.6 | ± 5.2 | 16.4 | 11.7 | 29.6 | 29 | 41 |
Asian | 5 | 15.5 | ± 3.7 | 13.9 | 12.2 | 20.5 | 1 | 6 |
Native Hawaiian or other Pacific islander | - | - | - | - | - | - | 1 | 1 |
Other | 1 | 15.1 | - | 15.1 | 15.1 | 15.1 | 2 | 3 |
Multiple | 1 | 13.5 | - | 13.5 | 13.5 | 13.5 | 4 | 5 |